Most Recent Articles about ABT
https://www.zacks.com/stock/news/2246922/abbott-s-abt-assert-iq-cardiac-monitor-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246922
Mar 27, 2024 - Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
zc:3860811962763104540
0
https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245409
Mar 25, 2024 - Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
zc:-3941071567344564522
0
https://www.zacks.com/stock/news/2243034/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243034
Mar 19, 2024 - Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre.
zc:2718418646040925232
0